In China, Government Data on Drugs Blocked From Public After Backlash
Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the ...
中国日报网4d
China reports decline in respiratory infectious diseases
The level of respiratory infectious diseases' spread in China has begun declining, a national viral disease researcher said ...
In China, Rare Dissent Over a Program to Save on Drug Costs
Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.
The National Law Review6d
China’s State Council Releases Antitrust Guidelines for the Pharmaceutical Sector Covering Reverse Payments and Evergreening
In follow up to the State Administration for Market Regulation’s (SAMR) draft of August 9, 2024, China’s State Council has ...
中国日报网6d
Nation deepens ASEAN health ties
The initiative is designed to deepen cooperation with members of the Belt and Road Initiative, particularly ASEAN nations, offering new opportunities for collaboration in healthcare and enhancing the ...